Capvizr
THE DEAL, AT A GLANCE

Link Cell Therapies

1/4 reviewed
Link Cell Therapies source image associated with the reported financing
Link Cell TherapiesLink Cell Therapies raised $30M Series A, announced 2026-09-29
Source-provided image · View source ↗
01Who is involvedBacked by $60 millionFrom the announcement

Summarized from the deal record's source announcement; not yet independently reviewed.

Read the announcement ↗
02What happenedLink Cell Therapies raised $30M Series A, announced 2026-09-29From the announcement

Summarized from the deal record's source announcement; not yet independently reviewed.

Read the announcement ↗
03Why it mattersThe money supports more logic-gated cancer cell therapy programs, including colorectal cancer development.Source-grounded · automated review · Explore ↗

Checked 2026-10-01 · Review due 2026-10-08

Read supporting source ↗
The additional capital will support…
Click a part to explore its evidence. The image is supplied by the cited source.Original record source ↗

Link Cell Therapies · Financing Record

Explore source-linked visual explanations for Link Cell Therapies. Unsupported claims are withheld while source review continues.

Record 13048 · Recorded date: 2026-09-29

Explore company records →
Free weekday briefing

Know which funding rounds matter before the first call.

Source-linked rounds, lead investors, and the signal behind the capital. One five-minute read.

Free · Unsubscribe anytime